Healthcare Utilization and Costs associated with Hereditary Hemorrhagic Telangiectasia Patients in a Large US Claims Database

OBJECTIVE: To assess the health care costs and utilization in patients with hereditary hemorrhagic telangiectasia (HHT) in the United States. PATIENTS AND METHODS: Retrospective analysis of patients with HHT diagnosed between 2007 and 2017 was performed using deidentified administrative claims data...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasan Albitar, Hasan Ahmad, Van Houten, Holly, Sangaralingham, Lindsey R., Knoedler, Meghan, Almodallal, Yahya, Alkurashi, Adham K., De Moraes, Alice Gallo, Cajigas, Hector, DuBrock, Hillary, Warad, Deepti, Demirel, Nadir, Krowka, Michael, Brinjikji, Waleed, Iyer, Vivek N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930864/
https://www.ncbi.nlm.nih.gov/pubmed/33718784
http://dx.doi.org/10.1016/j.mayocpiqo.2020.08.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930864/
https://www.ncbi.nlm.nih.gov/pubmed/33718784
http://dx.doi.org/10.1016/j.mayocpiqo.2020.08.010

Ejemplares similares